Here's a look at the news highlights from Asean countries in the Star-AseanPlus section for Friday (Feb 13, 2026) ...

From Love on Trial and Love Punch! to Mystery Arena, these 16 Japanese live-action movies of 2026 definitely deserve a spot ...

From Love on Trial and Sakamoto Days to Mag Mag, these 16 Japanese live-action movies of 2026 warrant a spot on your watchlist.

International competition may just be the theme of the sports world in 2026, and the return of the World Baseball Classic is a major part of the best-on-best action lined up for this year.

As the patents for "blockbusters"—drugs with annual sales exceeding $1 billion (approximately 1.4 trillion won)—approach ...

Korean Biosimilar Firms Capitalize on Global Patent Expirations Samsung Bioepis, Celltrion Target Keytruda, Dupixent ...

Daiichi Sankyo is strategically expanding its 5DXd ADCs portfolio to offset potential challenges from patent expirations. The company reported strong revenue growth across its ADC portfolio, with ...

Daiichi Sankyo Co., Ltd. (TICKER:4568.T) reported strong financial results for the third quarter of fiscal year 2025, surpassing market expectations with an earnings per share (EPS) of JPY 46.79, ...

DelveInsight's RET Fusion Targeted Therapies Market Size, Target Population, Competitive Landscape & Market Forecast report includes a comprehensive understanding of current treatment practices, ...

Daiichi Sankyo is eying new horizons for its leukemia med Vanflyta, with Genesis Pharma signing on to commercialize the drug in certain European countries. The exclusive license and supply agreement ...

A bodybuilding champion who won eight consecutive titles has died at the age of 30 due to a possible heart problem, according to reports. Wang Kun, a juggernaut in the Chinese bodybuilding community, ...